GI cancers
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
GI cancers
Jun 26, 2024, 14:33 |
Blog
NOM after IO in early-stage MSI-H GI cancers
Deniz Can Guven, The Editorial Board Member in BMC Cancer, shared on X: "Out in Cancer…
Jun 10, 2024, 16:08 |
Blog
Shubham Pant: Back in Kolkata after almost 2 decades for the GI Oncology Update
Shubham Pant, Professor at MD Anderson Cancer Center, shared on X/Twitter: "Back in the 'City of…
Jun 10, 2024, 06:13 |
Blog
Deniz Can Guven: Come and join us at ESMOGI24
Deniz Can Guven, Medical Oncologist at Health Sciences University, Elazığ City Hospital, shared on X: "Less…
May 28, 2024, 11:14 |
Societies
Shaalan Beg and Mohamed E. Salem discuss emerging CART-cell approaches in GI cancers - ASCO
ASCO recently shared a post on X: "Shaalan Beg of Science 37 and Mohamed E.…
May 20, 2024, 13:16 |
Opinion
Cathy Eng: Debate Between Drs. Lakshmi Rajdev and Nataliya Uboha on MSI Tumors
Cathy Eng shared on X: “2nd debate Great Debates & Updates: MSI Tumors: Does Anatomic Location…
May 19, 2024, 04:28 |
Blog
Mohd Aamir Qureshi: Research grant of INR 2.25 Crores has been accepted and sanctioned by the prestigious ICMR New Delhi
Mohd Aamir Qureshi, Researcher of Radiation Oncology, JN Medial College Aligarh Muslim University shared a…
Apr 28, 2024, 21:10 |
Drugs
Doug Rubinson: The best drug in GI cancers is 5-FU
Doug Rubinson, GI Medical Oncologist At Dana-Farber Cancer Centre, shared on X/Twitter: "In oncology, we…
Apr 10, 2024, 16:04 |
Blog
Impressive advancements in gastrointestinal endoscopy - European School of Oncology
European School of Oncology shared on LinkedIn: "Impressive advancements in gastrointestinal endoscopy over the last five…
All:
8
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube